Change over period: —
NSE · SUPRIYA
SUPRIYA
-41.6% from the 52-week high · +11.1% above the low
Supriya Lifescience Ltd. supplies active pharmaceuticals ingredients (“APIs”), with a focus on research and development. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2021-12-28. The company focuses on products in various therapeutic segments, such as Antihistamine, Anti-Allergic, Vitamins, Anesthetics, Ant-Malarial and Anti-Asthmatics. The company handles chemical reactions, such as Friedel Craft’s Acylation, Claisen Condensation, Grignard Reaction, Mannich Reaction, Ritter Reaction, Eschweiler Clark reaction, Hydrogenation, Chlorination, Bromination, Decyanation, Isocyanation, Ethoxylation, Nitration, Alkylation, Reduction, Oxidation, Etherification, Chlorosulphonation, Phosphorylation, Chiral resolution, Heterocyclic chemistry, Thermal ring expansion and Protection/Deprotection. Its manufacturing facilities include delineated areas for quality check; manufacturing areas with multiple clean rooms; engineering and maintenance; warehouse; materials and finished goods stores; in-house microbiological laboratory, and functional waste treatment plant.
The short version. Promoter holding was 68.3% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
SUPRIYA trades 41.6% below its 52-week high and 11.1% above its 52-week low.
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Down 0.08 pts over 8 quarters.
Up 0.55 pts over 8 quarters.
+10 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 68.3 | 68.3 | 68.3 | 68.3 | 68.3 | 68.3 | 68.3 | 68.3 | 0.0 |
| FII | 6.52 | 7.19 | 6.78 | 5.46 | 5.2 | 5.16 | 6.19 | 6.44 | -0.08 |
| DII | 4.92 | 4.26 | 4.86 | 5.22 | 5.01 | 5.7 | 5.3 | 5.47 | +0.55 |
| Public | 20.26 | 20.26 | 20.06 | 21.02 | 21.5 | 20.84 | 20.21 | 19.79 | -0.47 |
Mutual fund holdings · Oct 2026
20 schemes hold this stock
10 the month before.
- the Quantum Small Cap Fund3.75% of NAV
- ITI ELSS Tax Saver Fund1.87% of NAV
- ITI Large & Mid Cap Fund1.49% of NAV
- ITI Pharma and Healthcare Fund0.89% of NAV
- the Quantum Flexi Cap Fund0.83% of NAV
- WhiteOak Capital Pharma and Healthcare Fund0.59% of NAV
- Abakkus Flexi Cap Fund0.56% of NAV
- Motilal Oswal Nifty Microcap 250 Index Fund0.27% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for SUPRIYA are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about SUPRIYA
What is the SUPRIYA share price?
SUPRIYA (SUPRIYA) last closed at ₹625.00, up 1.66% on the day. Its 52-week range is ₹553.35 to ₹1,052.50.
What is the market cap of SUPRIYA?
SUPRIYA has a market capitalisation of about ₹4,948 crore. Its price-to-earnings ratio is 27.8.
How are SUPRIYA's latest results?
Promoter holding was 68.3% in Sep 2026, up 0.00 points over 8 quarters.
Who owns SUPRIYA?
As of Sep 2026, shareholding was: Promoter 68.3%, FII 6.44%, DII 5.47%, Public 19.79%.
How many mutual funds hold SUPRIYA?
20 mutual fund schemes held SUPRIYA in October 2026. That compares with 10 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 04 Sep 2025 · Final Dividend - Rs. 1
- 20 Sep 2024 · Final Dividend - Rs. 0.8
- 15 Sep 2023 · Final Dividend - Rs. 0.6
- 01 Sep 2022 · Final Dividend - Rs. 0.6
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.